DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...
Kingsview Wealth Management LLC cut its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 45.0% in the 4th quarter, according to the company in its most recent disclosure with the ...
Stifel Nicolaus analyst Mathew Blackman reiterated a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
In trading on Friday, shares of DexCom Inc (Symbol: DXCM) crossed above their 200 day moving average of $88.48, changing hands as high as $89.84 per share. DexCom Inc shares are currently trading ...
Stratos Wealth Partners LTD. purchased a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 2,583 shares of the medical device ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results